Patient P-02339
Synthetic patientMETA-24 · Day 169 · 55–64 · M · baseline S03Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
18%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S03
- Day 12 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
- Day 23 Patient accepted — Started DT-01 in the companion
- Day 28 GI symptom burden −11% vs expected — Dosing / Timing Recommendation DT-01
- Day 34 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 12.
Primary contributors, last 14 days
- Treatment adherence-8
- Toxicity+8
- GI instability-5
- Nutritional resilience+5
What helped?
- Dosing / Timing Recommendation DT-01Day 22Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable33 min
stable · +1.1 vs previous 14 d
Sleep duration
Wearable6 h
stable · +0.1 vs previous 14 d
Energy level
Daily log4.6/10
stable · +0.1 vs previous 14 d
Steps
Wearable3,028
improving · +207 vs previous 14 d
GI burden
Companion19.5/100
stable · -0.7 vs previous 14 d
Adherence
Companion88.1 %
stable · -2.3 vs previous 14 d
Sleep quality
Wearable42/100
improving · +1.9 vs previous 14 d
Glucose, CGM daily mean
CGM130 mg/dL
stable · -2.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 69 from the failing basin, 28 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -6.8 next day on high-intake days · n 19
Would not help
- Keep fat lowGI +5.3 next day on high-intake days · n 17
- Keep alcohol lowGI +5.1 next day on high-intake days · n 25
- Keep simple carbs lowGI +4.1 next day on high-intake days · n 23
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6.8supporter · 95%
- Dietary fat load+5.3detractor · 95%
- Alcohol+5.1detractor · 95%
- Simple carbohydrates+4.1detractor · 95%
- Ultra-processed food+3.5detractor · 84%
- Histamine load+0.8no signal · 17%
- Caffeine-0.6no signal · 15%
- Insoluble fibre+0.5no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑65
- WearableResting HR 75 bpm
- Wearable3,028 steps/day
- WearableShort sleep window
- Butyrate / short-chain fatty acid production ↓60
- MicrobiomeButyrate capacity 34/100
- MicrobiomeF. prausnitzii depleted
- Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 6.0 h, below personal baseline
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 34/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 47 ms
- Sleep
- 6.5 h
- Steps
- 3,124
- Resting HR
- 74 bpm
Daily log: GI score 20, nutritional resilience 64, adherence 88.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02093 | 39% | S05 | AD-05 | no change | 40 |
| P-02285 | 39% | S14 | AD-05 | no change | 39 |
| P-02031 | 38% | S12 | AD-05 | improved | 47 |
| P-02087 | 40% | S01 | BR-03 | no change | 40 |
| P-02483 | 40% | S06 | BR-03 | no change | 64 |
| P-02267 | 39% | S09 | BR-03 | no change | 45 |
| P-02522 | 37% | S01 | BR-03 | no change | 40 |
| P-02280 | 35% | S07 | BR-03 | no change | 50 |
| P-02235 | 52% | S14 | DT-01 | improved | 50 |
| P-02274 | 50% | S15 | DT-01 | improved | 50 |
| P-02685 | 49% | S16 | DT-01 | improved | 47 |
| P-02455 | 48% | S09 | DT-01 | improved | 50 |